MedTrace Logo

Abdominal or Transanal TME for Rectal Cancer Therapy

NCT04969107 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-08-08

No results posted yet for this study

Summary

This study assessed whether transanal TME in patients with rectal cancer is superior to open, laparoscopic, and robotic TME (abdominal TME (abTME)) regarding oncological outcome, postoperative morbidity and 90-day mortality.

Conditions

  • Survival
  • Postoperative Morbidity
  • Mortality
  • Recurrence

Interventions

PROCEDURE

taTME

Resection of rectal cancer with preparation of the mesorectal plane along the TME-plane in a rendezvous procedure of an abdominal and a transanal approach.

PROCEDURE

abdTME

Resection of rectal cancer with preparation of the mesorectal plane along the TME-plane in an abdominal Approach.

Sponsors & Collaborators

  • Cantonal Hospital of St. Gallen

    lead OTHER

Principal Investigators

  • Lukas Marti, Dr. med. · Leitender Arzt, Chirurige KSSG

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969107 on ClinicalTrials.gov